Women and children’s real-world economic and drug indicators from 2015 to 2019

References

• National Institutes of Health, Office of Research on Women’s Health. 2019 NIH–maternal morbidity and mortality booklet. 2019.
   Google Scholar
• World Health Organization. Health statistics and information systems. Geneva: World Health Organization; 2020. https://www.who.int/data/gho/publications/world-health-statistics
   Google Scholar
• Statistical Bureau of Hainan Province, Survey Office of National Bureau of Statistics in Hainan. Public Health and Social Services. Hainan Statistical yearbook-2020. Beijing: China Statistical Press; 2020. p. 479.
   Google Scholar
• WHO U, UNFPA, World Bank Group and the United Nations Population Division. Maternal mortality: levels and trends 2000 to 2017. 2019. https://www.who.int/publications/i/item/9789241516488
   Google Scholar
• Qiao J, Wang Y, Li X, et al. A Lancet Commission on 70 years of women’s reproductive, maternal, newborn, child, and adolescent health in China. Lancet. 2021 [2021 05 24];397(10293):2497–8. doi: 10.1016/S0140-6736(20)32708-2
   PubMed Web of Science ®Google Scholar
• Atif M, Sarwar MR, Azeem M, et al. Assessment of WHO/INRUD core drug use indicators in two tertiary care hospitals of Bahawalpur, Punjab, Pakistan. J Of Pharm Policy And Pract. 2016;9(1):27. doi: 10.1186/s40545-016-0076-4
   PubMedGoogle Scholar
• Ting JY, Synnes A, Roberts A, et al. Association between antibiotic use and neonatal mortality and morbidities in very low-birth-weight infants without culture-proven sepsis or necrotizing enterocolitis. JAMA Pediatr. 2016;170(12):1181. doi: 10.1001/jamapediatrics.2016.2132
   PubMed Web of Science ®Google Scholar
• The Lancet CA, Health. Infant and maternal mortality in the USA. The Lancet Child Adol Health. 2021;5(1):1. doi: 10.1016/S2352-4642(20)30369-2
   Web of Science ®Google Scholar
• National Development and Reform Commission. Report on China’s economic, social development plan. Beijing: National Development and Reform Commission. 2019.
   Google Scholar
• Hainan provincial bureau of statistics. Statistical bulletin on national economic and social development of Hainan province in 2019. Hainan: Hainan Provincial Bureau of Statistics; 2020. https://www.hainan.gov.cn/hainan/ndsj/202003/a03a4d8c72184b6b867bea6e70aa25b3.shtml
   Google Scholar
• Jun Z, Jingsong M, Guohua J, et al. Cross-sectional study of zero-medicine markup policy, prescribing trends and drug indicators using WHO/INRUD methodology in Chinese Jingzhou area. Pak J Pharm Sci. 2022 Jul;35(4):985–991.
   PubMed Web of Science ®Google Scholar
• The National Health Commission of the People’s Republic of China. National action plan to contain antimicrobial resistance (2016-2020). Beijing: National Health Commission; 2016. http://en.nhc.gov.cn/2016-08/26/c_70276.htm
   Google Scholar
• Husereau D, Drummond M, Augustovski F, et al. Consolidated Health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. Clin Ther. 2022 Feb;44(2):158–168. doi: 10.1016/j.clinthera.2022.01.011
   PubMed Web of Science ®Google Scholar
• Corrigan-Curay J, Sacks L, Woodcock J. Real-world evidence and real-world data for evaluating drug safety and effectiveness. JAMA. 2018 Sep 4;320(9):867–868.
   PubMed Web of Science ®Google Scholar
• Lasky T, Carleton B, Horton DB, et al. Real-world evidence to assess medication safety or effectiveness in children: systematic review. Drugs Real World Outcomes. 2020 Jun;7(2):97–107. doi: 10.1007/s40801-020-00182-y
   PubMedGoogle Scholar
• Ogrinc G, Fau - Davies L, Davies L, et al. SQUIRE 2.0 (standards for quality improvement reporting excellence): revised publication guidelines from a detailed consensus process. J Contin Educ Nurs. 2015;46(11):1938–2472. (Electronic). doi: 10.3928/00220124-20151020-02
   Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(11):1495–1499. doi: 10.1016/j.ijsu.2014.07.013
   PubMedGoogle Scholar
• WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health. ATC/DDD Index. WHO Collaborating Centre for Drug Statistics Methodology. 2020.
   Google Scholar
• Montecatine-Alonso E, Gil-Navarro MV, Fernandez-Llamazares CM, et al. Antimicrobial defined daily dose adjusted by weight: a proposal for antibiotic consumption measurement in children. Enferm Infec Microbiol Clin. 2019 May;37(5):301–306. doi: 10.1016/j.eimc.2018.07.011
   Google Scholar
• Crisafulli S, Sultana J, Ingrasciotta Y, et al. Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study. Expert Opin Drug Saf. 2019 Jun;18(6):497–509. doi: 10.1080/14740338.2019.1614165
   PubMed Web of Science ®Google Scholar
• Kourlaba G, Gkrania-Klotsas E, Kourkouni E, et al. Antibiotic prescribing and expenditures in outpatient adults in Greece, 2010 to 2013: evidence from real-world practice. Euro Surveill. 2016 Jun 30;21(26): doi: 10.2807/1560-7917.ES.2016.21.26.30266
   PubMedGoogle Scholar
• Freriksen JJM, van Seyen M, Judd A, et al. Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child. Aliment Pharmacol Ther. 2019 Oct;50(7):738–750. doi: 10.1111/apt.15476
   PubMed Web of Science ®Google Scholar
• Raminelli M, Hahn SR. Medicamentos na amamentação: quais as evidências? Ciência Saúde Coletiva. 2019 Feb;24(2):573–587. doi: 10.1590/1413-81232018242.30052016
   PubMedGoogle Scholar
• Huybrechts KF, Kulldorff M, Hernandez-Diaz S, et al. Active Surveillance of the safety of medications used in pregnancy. Am J Epidemiol. 2021 Jan 11;190(6):1159–1168. doi: 10.1093/aje/kwaa288
   PubMed Web of Science ®Google Scholar
• Huybrechts KF, Bateman BT, Hernández-Díaz S. Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy. Pharmacoepidemiol Drug Saf. 2019;28(7):906–922. doi: 10.1002/pds.4789
   PubMed Web of Science ®Google Scholar
• Weersink RA, Taxis K, Drenth JPH, et al. Prevalence of drug prescriptions and potential safety in patients with cirrhosis: a retrospective real-world study. Drug Saf. 2019;42(4):539–546. doi: 10.1007/s40264-018-0744-1
   PubMed Web of Science ®Google Scholar
• Chui CSL, Cowling BJ, Lim WW, et al. Patterns of inpatient antibiotic use Among public hospitals in Hong Kong from 2000 to 2015. Drug Saf. 2020;43(6):595–606. doi: 10.1007/s40264-020-00920-9
   PubMed Web of Science ®Google Scholar
• Araujo da Silva AR, Albernaz de Almeida Dias DC, Marques AF, et al. Role of antimicrobial stewardship programmes in children: a systematic review. Journal Of Hospital Infection. 2018 Jun;99(2):117–123. doi: 10.1016/j.jhin.2017.08.003
   PubMed Web of Science ®Google Scholar
• World Health Assembly. Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2019. https://iris.who.int/handle/10665/253236
   Google Scholar
• Mendelson M, Matsoso MP. The World Health Organization global action plan for antimicrobial resistance. S Afr Med J. 2015 Apr 6;105(5):325.
   PubMed Web of Science ®Google Scholar
• Hsia Y, Lee BR, Versporten A, et al. Use of the WHO access, watch, and reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries. Lancet Glob Health. 2019 Jul;7(7):e861–e71. doi: 10.1016/S2214-109X(19)30071-3
   PubMed Web of Science ®Google Scholar
• Frost HM, Knepper BC, Shihadeh KC, et al. A novel approach to evaluate antibiotic utilization across the spectrum of inpatient and ambulatory care and implications for prioritization of antibiotic stewardship efforts. Clin Infect Dis. 2020 Apr 10;70(8):1675–1682. doi: 10.1093/cid/ciz466
   PubMed Web of Science ®Google Scholar
• Hu F, Zhu D, Wang F, et al. Current Status and trends of antibacterial resistance in China. Clin Infect Dis. 2018 Nov 13;67(suppl_2):S128–S34.
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. Status Report on antimicrobial Administration and antimicrobial resistance in China. Beijing; 2020.
   Google Scholar
• Atif M, Sarwar MR, Azeem M, et al. Assessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan. BMC Health Serv Res. 2016;16(1):684. doi: 10.1186/s12913-016-1932-2
   PubMed Web of Science ®Google Scholar
• Yimenu DK, Emam A, Elemineh E, et al. Assessment of antibiotic prescribing patterns at outpatient pharmacy using World Health Organization prescribing indicators. J Prim Care Community Health. 2019 Jan-Dec;10:1–8. doi: 10.1177/2150132719886942
   Web of Science ®Google Scholar
• Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015). BMC Public Health. 2016;16(1):724. doi: 10.1186/s12889-016-3428-8
   PubMed Web of Science ®Google Scholar